The usage of low-molecular weight heparin during percutaneous coronary interventions

Abstract

Use of LMWH during PTCA in stable angina. Evaluation of number, activity and aggregation response of platelets and thrombin activity.

Difference in complication occurence after PTCA in patients treated with UFH and LMWH.

Keywords

• low-molecular weight heparin
• unfractionated heparin
• percutaneous coronary interventions